Key Trends and Insights into the Chorionic Gonadotropin Market: Growth Rate and Opportunities to 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the chorionic gonadotropin market grown over the years?
Over the past few years, the market size for chorionic gonadotropin has seen consistent growth. It is projected to increase from $1,260 million in 2024 to $1,340 million in 2025, demonstrating a compound annual growth rate (CAGR) of 4.4%. The notable growth in previous years is due to an elevated understanding of hCG amongst healthcare experts and patients, a surge in its use for treating hormonal imbalance disorders, advanced affordability, advancements in healthcare facilities, and a rising demand for assisted reproduction.
What Is the forecasted market size and growth rate for the chorionic gonadotropin market?
The market for chorionic gonadotropin is projected to experience consistent growth in the coming years, expected to reach $1,710 million in 2029 with a compound annual growth rate (CAGR) of 4%. The forecasted growth is credited to rising instances of infertility, heightened awareness of reproductive health, increased use of assisted reproductive technologies, growing cases of hypogonadism in the elderly, and the development of healthcare infrastructure. Notable trends within the forecast period include technological innovations, advancements in recombinant technology, growth within assisted reproductive technology, augmentations in research and development, and creative advancements in drug delivery systems and formulations.
Get your chorionic gonadotropin market report here!
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report
What are the major factors driving growth in the chorionic gonadotropin market?
The chorionic gonadotropin market is projected to grow due to the rising incidence of infertility. Infertility is defined as the incapacity to conceive a child despite a year of regular, unprotected sex for couples below 35, or after six months for those 35 or older. Delayed childbearing contributes to this growing issue, along with lifestyle habits like obesity and smoking that negatively affect reproductive health. Chorionic Gonadotropin (hCG), in response, is used to induce ovulation, support pregnancy maintenance, and stimulate testosterone production to improve sperm count. The World Health Organization (WHO) reported in April 2023 that around 17.5% of the global adult population or 1 in 6 people suffers from infertility, signifying the need for affordable, quality fertility care. Thus, the increasing occurrence of infertility issues is fueling the expansion of the chorionic gonadotropin market. The advancement of assisted reproductive technologies is also contributing to the growth of the chorionic gonadotropin market. Assisted reproductive technologies (ART) are medical procedures aimed to help those unable to conceive naturally. Higher infertility rates, delayed childbearing, medical advancements, and improved accessibility account for the rise in ART. Chorionic gonadotropin (hCG) plays a crucial role in ART, facilitating ovulation and supporting the luteal phase post-embryo transfer to ensure successful fertilization and early pregnancy. For instance, MJH Life Sciences announced in April 2024 an increase in the number of ART cycles performed, with egg freezing cycles escalating from 24,560 in 2021 to 29,803 in 2022. Therefore, the development of assisted reproductive technologies significantly drives the expansion of the chorionic gonadotropin market.
What key areas define the segmentation of the global chorionic gonadotropin Market?
The chorionic gonadotropinmarket covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp
What are the top market players propelling the growth of the chorionic gonadotropin industry?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals
What are the key trends shaping the future of the chorionic gonadotropin market?
A significant trend in the human chorionic gonadotropin market is the emphasis on the development of novel solutions such as pregnancy tests based on saliva, aimed at enhancing comfort, precision, and reach. Saliva-based pregnancy tests represent a non-intrusive diagnostic approach that ascertains pregnancy by scrutinizing a woman’s spit for the presence of human chorionic gonadotropin (hCG), a hormone secreted during pregnancy. For example, in June 2023, Salignostics, a biotech firm from Israel, introduced the first ever pregnancy test based on saliva globally. This ground-breaking product gives women the ability to confirm pregnancy using a saliva specimen as opposed to urine, revealing the hCG (human chorionic gonadotropin) hormone with outcomes ready in a matter of 5 to 15 minutes. Salistick provides a more relaxed and handy testing experience, permitting users to carry out the test anywhere and share the experience with their partners or close relations.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888
What regions are dominating the chorionic gonadotropin market growth?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Rheumatoid Arthritis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2025
Global Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
